<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">etÂ </span>
   <span class="font24">viral </span>
   <span class="font20">IFN </span>
   <span class="font19">type </span>
   <span class="font17">IFNs </span>
   <span class="font17">III </span>
   <span class="font17">SARS-CoV </span>
   <span class="font16">response </span>
   <span class="font16">IFN-I </span>
   <span class="font16">respiratory </span>
   <span class="font15">mice </span>
   <span class="font15">coronavirus </span>
   <span class="font14">COVID- </span>
   <span class="font14">infection </span>
   <span class="font14">Type </span>
   <span class="font14">antiviral </span>
   <span class="font14">signaling </span>
   <span class="font14">innate </span>
   <span class="font13">host </span>
   <span class="font13">{border-style </span>
   <span class="font13">IFN-Î± </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">interferon </span>
   <span class="font13">treatment </span>
   <span class="font13">disease </span>
   <span class="font13">px;} </span>
   <span class="font13">replication </span>
   <span class="font13">severe </span>
   <span class="font13">syndrome </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">SARS </span>
   <span class="font13">induction </span>
   <span class="font13">immune </span>
   <span class="font13">virus </span>
   <span class="font12">MERS-CoV </span>
   <span class="font12">acute </span>
   <span class="font12">cells </span>
   <span class="font12">human </span>
   <span class="font12">patients </span>
   <span class="font12">IFN-Î» </span>
   <span class="font12">Virol. </span>
   <span class="font12">clinical </span>
   <span class="font12">control </span>
   <span class="font12">infection, </span>
   <span class="font12">studies </span>
   <span class="font12">Coronavirus </span>
   <span class="font12">IFN-Î² </span>
   <span class="font12">RNA </span>
   <span class="font12">early </span>
   <span class="font12">expression </span>
   <span class="font12">pro-inflammatory </span>
   <span class="font12">protein </span>
   <span class="font12">recognition </span>
   <span class="font12">role </span>
   <span class="font12">East </span>
   <span class="font12">combination </span>
   <span class="font12">therapeutic </span>
   <span class="font11">COVID-. </span>
   <span class="font11">TLR, </span>
   <span class="font11">administration </span>
   <span class="font11">lung </span>
   <span class="font11">mouse </span>
   <span class="font11">protection </span>
   <span class="font11">(Channappanavar </span>
   <span class="font11">ISG </span>
   <span class="font11">ISGs </span>
   <span class="font11">MERS </span>
   <span class="font11">Middle </span>
   <span class="font11">epithelial </span>
   <span class="font11">proteins </span>
   <span class="font11">reduced </span>
   <span class="font11">response. </span>
   <span class="font11">coronaviruses </span>
   <span class="font11">cytokines </span>
   <span class="font11">delayed </span>
   <span class="font11">genes </span>
   <span class="font11">infections </span>
   <span class="font11">interferons </span>
   <span class="font11">protective </span>
   <span class="font11">px; </span>
   <span class="font11">sensing </span>
   <span class="font11">therapy </span>
   <span class="font11">upper </span>
   <span class="font11">{font-family </span>
   <span class="font11">ORF </span>
   <span class="font11">factors </span>
   <span class="font11">font-size </span>
   <span class="font11">function </span>
   <span class="font11">including </span>
   <span class="font11">inflammation </span>
   <span class="font11">load </span>
   <span class="font11">model </span>
   <span class="font11">nsp </span>
   <span class="font11">study </span>
   <span class="font11">various </span>
   <span class="font11">(FigureÂ </span>
   <span class="font11">Host </span>
   <span class="font11">IAV </span>
   <span class="font11">IFN-III </span>
   <span class="font11">Innate </span>
   <span class="font11">ORFb </span>
   <span class="font11">Respiratory </span>
   <span class="font11">SARS-CoV, </span>
   <span class="font11">addition </span>
   <span class="font11">associated </span>
   <span class="font11">compared </span>
   <span class="font11">double; </span>
   <span class="font11">effects </span>
   <span class="font11">highly </span>
   <span class="font11">induce </span>
   <span class="font11">initial </span>
   <span class="font11">potent </span>
   <span class="font11">prevent </span>
   <span class="font11">prophylactic </span>
   <span class="font11">research </span>
   <span class="font11">responses </span>
   <span class="font11">results </span>
   <span class="font11">similar </span>
   <span class="font11">spread </span>
   <span class="font11">strategy </span>
   <span class="font11">transcription </span>
   <span class="font11">use </span>
   <span class="font10">Elsevier </span>
   <span class="font10">IFNLR </span>
   <span class="font10">IFNs, </span>
   <span class="font10">Ifnarâˆ’/âˆ’ </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Interferon </span>
   <span class="font10">MERS-CoV, </span>
   <span class="font10">Med. </span>
   <span class="font10">airway </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cap </span>
   <span class="font10">critical </span>
   <span class="font10">cytokine </span>
   <span class="font10">different </span>
   <span class="font10">effective </span>
   <span class="font10">efficacy </span>
   <span class="font10">expressed </span>
   <span class="font10">hepatitis </span>
   <span class="font10">induced </span>
   <span class="font10">lethal </span>
   <span class="font10">levels </span>
   <span class="font10">mechanisms </span>
   <span class="font10">pathogenic </span>
   <span class="font10">peak </span>
   <span class="font10">production </span>
   <span class="font10">receptor </span>
   <span class="font10">receptors </span>
   <span class="font10">recombinant </span>
   <span class="font10">relative </span>
   <span class="font10">required </span>
   <span class="font10">retrospective </span>
   <span class="font10">revealed </span>
   <span class="font10">ribavirin </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">susceptible </span>
   <span class="font10">trial </span>
   <span class="font10">used </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Frieman </span>
   <span class="font10">(Lokugamage </span>
   <span class="font10">ACE </span>
   <span class="font10">China </span>
   <span class="font10">IRF </span>
   <span class="font10">Immune </span>
   <span class="font10">Infection </span>
   <span class="font10">MERS. </span>
   <span class="font10">RIG-I </span>
   <span class="font10">Research </span>
   <span class="font10">Rev. </span>
   <span class="font10">SARS-CoV-infected </span>
   <span class="font10">STAT </span>
   <span class="font10">Syndrome </span>
   <span class="font10">Therapeutic </span>
   <span class="font10">accessory </span>
   <span class="font10">achieve </span>
   <span class="font10">activates </span>
   <span class="font10">approved </span>
   <span class="font10">benefit </span>
   <span class="font10">bold </span>
   <span class="font10">caused </span>
   <span class="font10">cell </span>
   <span class="font10">centre </span>
   <span class="font10">clearance </span>
   <span class="font10">contrast, </span>
   <span class="font10">courier; </span>
   <span class="font10">days </span>
   <span class="font10">defense </span>
   <span class="font10">differences </span>
   <span class="font10">em; </span>
   <span class="font10">factor </span>
   <span class="font10">increased </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibits </span>
   <span class="font10">interferon-stimulated </span>
   <span class="font10">inÂ </span>
   <span class="font10">kinetics </span>
   <span class="font10">lack </span>
   <span class="font10">late </span>
   <span class="font10">low </span>
   <span class="font10">macaques </span>
   <span class="font10">mild </span>
   <span class="font10">models </span>
   <span class="font10">mortality </span>
   <span class="font10">multiple </span>
   <span class="font10">natural </span>
   <span class="font10">nuclear </span>
   <span class="font10">older </span>
   <span class="font10">ongoing </span>
   <span class="font10">pathology </span>
   <span class="font10">potential </span>
   <span class="font10">primary </span>
   <span class="font10">pt;} </span>
   <span class="font10">replication, </span>
   <span class="font10">reported </span>
   <span class="font10">resource </span>
   <span class="font10">review </span>
   <span class="font10">showed </span>
   <span class="font10">single </span>
   <span class="font10">suggest </span>
   <span class="font10">suppress </span>
   <span class="font10">timing </span>
  </p>
 </body>
</html>
